Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

However, you can queue the update for the Mounts of Mayhem game drop manually as well. The launcher lets players initiate updates on the existing version, upgrading ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Grandfather, 3-month-old granddaughter dead after violent dog attack Opinion: Why Marjorie ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

Investors in Recursion (NASDAQ: RXRX) seemed only mildly fazed by Wednesday’s series of company announcements. The artificial intelligence (AI)-based drug developer’s stock barely moved on Wednesday, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Recursion ...

Anyone who has practiced diplomacy will be familiar with the whiplash that comes from watching carefully prepared talking points get rendered obsolete in real time. I experienced it last week in China ...

The GPU leader continues to invest in AI-related companies. Its mere involvement with these businesses makes them worth a look for retail investors. If that sounds a bit crazy, it's not. Lots of ...

APK teardown shows Samsung is working on a new launcher shortcut for AI services. The shortcut would respond to questions with three-sentence answers. We’re expecting this feature to be released ...